Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
J Cosmet Dermatol ; 20(9): 2758-2764, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-33252188

RESUMO

BACKGROUND: Facial care treatments have grown a remarkable demand for effective and minimally invasive techniques with fast recovery time. Plasma technology is a nonsurgical alternative technique for skin rejuvenation. AIMS: We assessed patient satisfaction and symptoms after upper eyelid blepharoplasty with plasma technology. PATIENTS/METHODS: Observational study including 16 patients submitted to upper eyelid blepharoplasty using plasma technology to treat dermatochalasis. Patient satisfaction, symptoms, and quality of life were assessed using 2 questionnaires at follow-up days 7 and 30. Also, the answers were correlated with age, Fitzpatrick skin type, and quantity of eyelid skin treated with plasma. RESULTS: All 16 patients were treated and completed the survey. Fourteen (87.5%) were female, and the mean age was 50.5 years. Physical appearance was the most relevant factor impacting on quality of life at first week postoperative. Regarding satisfaction with results, most patients stated higher level of satisfaction at day 7 follow-up analysis (P = .038). Less impact on quality of life and higher satisfaction was associated with eyelid-treated area (P = .044 and P = .036) and Fitzpatrick skin type (P = .043) at 7 and 30 days after procedure, respectively. Eyelid edema and itching were the symptoms most reported at 7 and 30 days, respectively. CONCLUSIONS: Upper blepharoplasty with plasma is a minimally invasive treatment with low impact on quality of life. However, overall patient satisfaction is questionable when considering less willing of undergoing procedure again and decreased expectation with results over postoperative period. Symptoms are reported mainly at the first week after procedure.


Assuntos
Blefaroplastia , Blefaroptose , Blefaroplastia/efeitos adversos , Blefaroptose/cirurgia , Pálpebras/cirurgia , Feminino , Humanos , Pessoa de Meia-Idade , Satisfação do Paciente , Satisfação Pessoal , Qualidade de Vida
2.
Rev. bras. oftalmol ; 80(4): e0015, 2021. graf
Artigo em Inglês | LILACS | ID: biblio-1288631

RESUMO

ABSTRACT The authors present a case of lupus miliaris disseminatus faciei , a rare skin disease of unknown etiology, which may cause unaesthetic scarring due to its difficult treatment. The histopathological examination of epithelioid granulomas with caseating necrosis, together with the clinical features, are important for diagnosis and early treatment with better results. Despite difficult and unsatisfactory treatment, there are ongoing studies on therapy to improve aesthetic and social impairment. This case report describes an initial misdiagnosis delaying appropriate treatment, and highlights the value of physical examination and clinical judgment for another pathological examination, whenever necessary, aiming at better treatment outcomes in daily practice.


RESUMO Os autores apresentam um caso de lupus miliaris disseminatus faciei , uma dermatose rara, de etiologia desconhecida, que pode deixar cicatrizes não estéticas, pela dificuldade de tratamento. O exame histopatológico de granulomas compostos por células epitelioides, com necrose caseosa, e as características clínicas, são importantes para o diagnóstico e tratamento precoce, com melhores resultados. Apesar do tratamento difícil e insatisfatório, há estudos em andamento sobre terapias para melhorar o comprometimento estético e social. Este relato de caso descreve um diagnóstico inicial errôneo, que atrasou o tratamento adequado, e destaca o valor do exame físico e raciocínio clínico para solicitar outro exame anatomopatológico, quando necessário, de forma a obter melhores desfechos com o tratamento, na prática diária.


Assuntos
Humanos , Feminino , Adulto , Doenças Palpebrais/patologia , Doenças Palpebrais/tratamento farmacológico , Dermatoses Faciais/patologia , Dermatoses Faciais/tratamento farmacológico , Tetraciclina/uso terapêutico , Prednisona/uso terapêutico , Isotretinoína/uso terapêutico , Cicatriz , Tacrolimo/uso terapêutico , Rosácea/patologia , Rosácea/tratamento farmacológico , Dapsona/uso terapêutico , Granuloma/patologia , Granuloma/tratamento farmacológico , Lúpus Vulgar/patologia , Lúpus Vulgar/tratamento farmacológico , Minociclina/uso terapêutico
3.
Arq. bras. oftalmol ; 73(5): 469-473, Sept.-Oct. 2010. ilus
Artigo em Português | LILACS | ID: lil-570514

RESUMO

O blefaroespasmo essencial é uma distonia focal caracterizada por contrações involuntárias, espasmódicas e bilaterais dos músculos orbicular da pálpebra, corrugador, prócerus e depressor do supercílio. Trata-se de uma doença rara, cujo diagnóstico é frequentemente tardio, o que permite a progressão dos sintomas até quadros de cegueira funcional. Nesse estudo, por meio de revisão da literatura, descreve-se as principais características da doença, incluindo os seguintes aspectos: histórico, epidemiologia, etiologia, quadro clí­nico, diagnóstico diferencial e tratamento.


Essential blepharospasm is a focal distonia characterized by involuntary, spasmodic, bilateral contractions of eyelid protractors. This is a rare disease, which diagnosis is frequently late and symptoms may progress until functional blindness. In this article, we perform a review and describe the most important features of the disease, including historical aspects, epidemiology, etiology, clinical findings, differential diagnosis and treatment.


Assuntos
Humanos , Blefarospasmo , Blefarospasmo/diagnóstico , Blefarospasmo/etiologia , Blefarospasmo/terapia
4.
Arq Bras Oftalmol ; 73(5): 469-73, 2010.
Artigo em Português | MEDLINE | ID: mdl-21225137

RESUMO

Essential blepharospasm is a focal distonia characterized by involuntary, spasmodic, bilateral contractions of eyelid protractors. This is a rare disease, which diagnosis is frequently late and symptoms may progress until functional blindness. In this article, we perform a review and describe the most important features of the disease, including historical aspects, epidemiology, etiology, clinical findings, differential diagnosis and treatment.


Assuntos
Blefarospasmo , Blefarospasmo/diagnóstico , Blefarospasmo/etiologia , Blefarospasmo/terapia , Humanos
5.
Ophthalmic Plast Reconstr Surg ; 25(4): 280-3, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19617785

RESUMO

PURPOSE: To analyze the results of treatment of eyelid xanthelasma (EX) with 70% trichloroacetic acid (TCA) with regard to efficacy, cosmetic appearance, patient satisfaction, and recurrence rate. METHODS: Twenty-four patients with EX of up to one third of the affected palpebral area were treated with 70% TCA. All patients were photographed at the start of treatment and 3 months after the last application. The recurrence rate was analyzed at the end of 6 months of treatment. RESULTS: The average number of applications of 70% TCA until the xanthelasma resolved was 1.5. Eleven patients (45.8%) had an excellent result, 8 (33.3%) a good result, and 5 (20.8%) had a satisfactory result. The most common complication was hypopigmentation (33.3%). All patients reported an improved final cosmetic result. Six patients (25%) treated with 70% TCA had a recurrence 6 months after treatment. CONCLUSIONS: The results of prospective treatment of 24 patients with EX with 70% TCA indicated that this is a simple and effective method, achieves a satisfactory cosmetic result, has an acceptable recurrence rate, and high patient satisfaction.


Assuntos
Cáusticos/administração & dosagem , Doenças Palpebrais/tratamento farmacológico , Ácido Tricloroacético/uso terapêutico , Xantomatose/tratamento farmacológico , Adulto , Idoso , Relação Dose-Resposta a Droga , Doenças Palpebrais/patologia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Soluções Oftálmicas , Satisfação do Paciente , Estudos Prospectivos , Resultado do Tratamento , Xantomatose/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...